| Host: | Rabbit |
| Applications: | IHC-P |
| Reactivity: | T.gondii |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | Rabbit polyclonal antibody anti-Toxoplasma godii is suitable for use in Immunohistochemistry research applications. |
| Clonality : | Polyclonal |
| Conjugation: | Unconjugated |
| Isotype: | IgG |
| Formulation: | Tris-HCI buffer containing stabilizing protein (BSA) and <0.1% ProClin |
| Purification: | Affinity purified |
| Dilution Range: | 1:100-200 |
| Storage Instruction: | Store at 2‐8°C for up to 24 months. Predilute: Ready to use, no reconstitution necessary. Concentrate: Use dilution range and appropriate lab‐standardized diluent. Stability after dilution: 7 days at 24°C, 3 months at 2‐8°C, 6months at ‐20°C. |
| Specificity: | Positive control: Toxoplasma Gondii infected tissue |
| Immunogen: | Toxoplasma gondii |
| Background | Toxoplasma gondii, a single-celled parasite, causes the disease toxoplasmosis. The life cycle of Toxoplasma gondii includes two phases: the intestinal (or enteroepithelial) and extraintestinal phases. The intestinal phase produces oocysts and occurs only in wild and domesticated cats. The extra-intestinal phase occurs in all infected animals and produces tachyzoites (actively proliferating trophozoites) and, eventually, bradyzoites (slowly growing trophozoites) or zoitocysts. Toxoplasma gondii infects tissue of the gastrointestinal tract, brain and lung in immunocompromised patients. |
Information sourced from Uniprot.org